Show simple item record

dc.contributor.authorCheekatla, Satyanarayana Swamy
dc.contributor.authorTripathi, Deepak
dc.contributor.authorVenkatasubramanian, Sambasivan
dc.contributor.authorNathella, Pavan Kumar
dc.contributor.authorPaidipally, Padmaja
dc.contributor.authorIshibashi, Munenori
dc.contributor.authorWelch, Elwyn
dc.contributor.authorTvinnereim, Amy R.
dc.contributor.authorIkebe, Mitsuo
dc.contributor.authorValluri, Vijaya Lakshmi
dc.contributor.authorBabu, Subash
dc.contributor.authorKornfeld, Hardy
dc.contributor.authorVankayalapati, Ramakrishna
dc.date2022-08-11T08:09:46.000
dc.date.accessioned2022-08-23T16:42:49Z
dc.date.available2022-08-23T16:42:49Z
dc.date.issued2016-10-26
dc.date.submitted2017-02-10
dc.identifier.citationPLoS Pathog. 2016 Oct 26;12(10):e1005972. doi: 10.1371/journal.ppat.1005972. eCollection 2016.. <a href="http://dx.doi.org/10.1371/journal.ppat.1005972">Link to article on publisher's site</a>.
dc.identifier.issn1553-7366 (Linking)
dc.identifier.doi10.1371/journal.ppat.1005972
dc.identifier.pmid27783671
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40170
dc.description.abstractIn this study, we developed a mouse model of type 2 diabetes mellitus (T2DM) using streptozotocin and nicotinamide and identified factors that increase susceptibility of T2DM mice to infection by Mycobacterium tuberculosis (Mtb). All Mtb-infected T2DM mice and 40% of uninfected T2DM mice died within 10 months, whereas all control mice survived. In Mtb-infected mice, T2DM increased the bacterial burden and pro- and anti-inflammatory cytokine and chemokine production in the lungs relative to those in uninfected T2DM mice and infected control mice. Levels of IL-6 also increased. Anti-IL-6 monoclonal antibody treatment of Mtb-infected acute- and chronic-T2DM mice increased survival (to 100%) and reduced pro- and anti-inflammatory cytokine expression. CD11c+ cells were the major source of IL-6 in Mtb-infected T2DM mice. Pulmonary natural killer (NK) cells in Mtb-infected T2DM mice further increased IL-6 production by autologous CD11c+ cells through their activating receptors. Anti-NK1.1 antibody treatment of Mtb-infected acute-T2DM mice increased survival and reduced pro- and anti-inflammatory cytokine expression. Furthermore, IL-6 increased inflammatory cytokine production by T lymphocytes in pulmonary tuberculosis patients with T2DM. Overall, the results suggest that NK-CD11c+ cell interactions increase IL-6 production, which in turn drives the pathological immune response and mortality associated with Mtb infection in diabetic mice.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=27783671&dopt=Abstract">Link to Article in PubMed</a>
dc.rightsThis is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/
dc.subjectImmunology and Infectious Disease
dc.subjectMicrobiology
dc.subjectNutritional and Metabolic Diseases
dc.titleNK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection
dc.typeJournal Article
dc.source.journaltitlePLoS pathogens
dc.source.volume12
dc.source.issue10
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3974&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/2969
dc.identifier.contextkey9667418
refterms.dateFOA2022-08-23T16:42:50Z
html.description.abstract<p>In this study, we developed a mouse model of type 2 diabetes mellitus (T2DM) using streptozotocin and nicotinamide and identified factors that increase susceptibility of T2DM mice to infection by Mycobacterium tuberculosis (Mtb). All Mtb-infected T2DM mice and 40% of uninfected T2DM mice died within 10 months, whereas all control mice survived. In Mtb-infected mice, T2DM increased the bacterial burden and pro- and anti-inflammatory cytokine and chemokine production in the lungs relative to those in uninfected T2DM mice and infected control mice. Levels of IL-6 also increased. Anti-IL-6 monoclonal antibody treatment of Mtb-infected acute- and chronic-T2DM mice increased survival (to 100%) and reduced pro- and anti-inflammatory cytokine expression. CD11c+ cells were the major source of IL-6 in Mtb-infected T2DM mice. Pulmonary natural killer (NK) cells in Mtb-infected T2DM mice further increased IL-6 production by autologous CD11c+ cells through their activating receptors. Anti-NK1.1 antibody treatment of Mtb-infected acute-T2DM mice increased survival and reduced pro- and anti-inflammatory cytokine expression. Furthermore, IL-6 increased inflammatory cytokine production by T lymphocytes in pulmonary tuberculosis patients with T2DM. Overall, the results suggest that NK-CD11c+ cell interactions increase IL-6 production, which in turn drives the pathological immune response and mortality associated with Mtb infection in diabetic mice.</p>
dc.identifier.submissionpathoapubs/2969
dc.contributor.departmentDepartment of Medicine, Division of Pulmonary, Allergy and Clinical Care Medicine
dc.source.pagese1005972


Files in this item

Thumbnail
Name:
journal.ppat.1005972.PDF
Size:
6.334Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Except where otherwise noted, this item's license is described as This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.